Cancer Core Europe: Karolinska Institute
20 Oct 2014
Cancer Core Europe: Karolinska Institute
Cancer Core Europe: Questions and answers
TAT 2015: Biological underpinnings of targeted therapies and the importance of dialogue and collaboration
TAT 2015: Cutting edge research and unique interaction between academia and industry
Meeting highlights from the 12th iwNHL 2014: Day 1
Meeting highlights from the 12th iwNHL 2014: Day 2
ESMO 2014 Editor's roundup
vandetanib improves PFS in thyroid cancer
E-hospital: Fully coordinated cancer care and research in Europe
ESMO Highlights: Breast cancer
Cancer care in developing countries
Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma